Search results
N40.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Benign prostatic hyperplasia with lower urinary tract symp; The 2025 edition of ICD-10-CM N40.1 became effective on October 1, 2024.
26 wrz 2020 · These codes serve as a universal language that enables healthcare professionals to communicate the diagnosis effectively, ensuring consistency and accuracy in medical documentation. The primary ICD-10 code used for BPH diagnosis is N40. This code represents “Enlarged prostate without lower urinary tract symptoms.”
N40.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Benign prostatic hyperplasia without lower urinry tract symp; The 2025 edition of ICD-10-CM N40.0 became effective on October 1, 2024.
N40.1 is a billable diagnosis code used to specify a medical diagnosis of benign prostatic hyperplasia with lower urinary tract symptoms. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
N40 is a non-billable diagnosis code for benign prostatic hyperplasia, use codes with a higher level of specificity: N40.0, N40.1, N40.2 or N40.3.
Benign prostatic hyperplasia (BPH), also called benign enlargement of the prostate (BEP or BPE), adenofibromyomatous hyperplasia and benign prostatic hypertrophy (technically incorrect usage), is a benign (noncancerous) increase in size of the prostate.
Benign prostatic hyperplasia (BPH), also called benign enlargement of the prostate (BEP or BPE), adenofibromyomatous hyperplasia and benign prostatic hypertrophy (technically incorrect usage), is a benign (noncancerous) increase in size of the prostate.
